NOVEL ANTI-CD19 ANTIBODIES - WUXI BIOLOGICS SHANGHAI CO LTD

Title:

NOVEL ANTI-CD19 ANTIBODIES

Document Type and Number:

WIPO Patent Application WO/2019/057100

Kind Code:

A1

Abstract:

Provided are anti-CD19 antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same, and the uses thereof.

More Like This:

WO/2020/247827	ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF
WO/2023/167680	ANTI-CD73 ANTIBODIES AND USE THEREOF
JP7410141	Anti-claudin-18.2 and anti-4-1BB bispecific antibodies and their uses

Inventors:

LI JING (CN)
LIU JIEYING (CN)

Application Number:

PCT/CN2018/106619

Publication Date:

March 28, 2019

Filing Date:

September 20, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

WUXI BIOLOGICS SHANGHAI CO LTD (CN)
WUXI BIOLOGICS CAYMAN INC (GB)

International Classes:

C07K16/30; A61K39/395; A61P35/00; C07K16/28; C12N15/13

Domestic Patent References:

WO2012010561A1	2012-01-26
WO2008022152A2	2008-02-21
WO2012010562A1	2012-01-26

Foreign References:

US20080260731A1

2008-10-23

Other References:

DATABASE GenBank 25 July 2016 (2016-07-25), TILLMAN, D.M. ET AL.: "immunoglobulin variable region, partial [Mus musculus domesticus", XP055583911, Database accession no. CAA80057.1
See also references of EP 3684820A4

Attorney, Agent or Firm:

JUN HE LAW OFFICES (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: NOVEL ANTI-CD3EPSILON ANTIBODIES

Next Patent: BLOOD SAMPLING DEVICE PROVIDED WITH ELASTIC BRIDGE BUFFER STRUCTURE